biospecimen__admin__batch_number	399.48.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	9F6C0DDC-2C93-40E0-BF7F-92F2906488F4
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-G3-AAV7-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-G3-AAV7-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-G3-AAV7-01A
biospecimen__bio__biospecimen_barcode_bottom	0164104718
biospecimen__bio__day_of_creation	05
biospecimen__bio__day_of_shipment	26
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	02
biospecimen__bio__month_of_shipment	03
biospecimen__bio__pathology_report_file_name	TCGA-G3-AAV7.0F368084-04F6-4DCE-9ADF-6B3B94D274AB.pdf
biospecimen__bio__plate_column	10
biospecimen__bio__plate_id	A38M
biospecimen__bio__plate_row	G
biospecimen__bio__quantity	3.40
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2014
biospecimen__bio__year_of_shipment	2014
biospecimen__shared__bcr_patient_barcode	TCGA-G3-AAV7
biospecimen__shared__patient_id	AAV7
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	24C2FE01-F88A-48B3-B80E-01A77501D459
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.3
clinical__chol_lihc_shared__albumin_result_specified_value	4
clinical__chol_lihc_shared__albumin_result_upper_limit	4.8
clinical__chol_lihc_shared__bilirubin_lower_limit	0
clinical__chol_lihc_shared__bilirubin_upper_limit	0.9
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.6
clinical__chol_lihc_shared__creatinine_upper_limit	1.4
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	1.1
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	10
clinical__chol_lihc_shared__fetoprotein_outcome_value	3
clinical__chol_lihc_shared__fibrosis_ishak_score	5 - Nodular Formation and Incomplete Cirrhosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	Hepatitis B
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	0.9
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	1.1
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	400
clinical__chol_lihc_shared__prothrombin_time_result_value	1
clinical__chol_lihc_shared__specimen_collection_method_name	Segmentectomy, Multiple
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.4
clinical__chol_lihc_shared__vascular_tumor_cell_type	Micro
clinical__clin_shared__age_at_initial_pathologic_diagnosis	38
clinical__clin_shared__bcr_followup_barcode	TCGA-G3-AAV7-F67249
clinical__clin_shared__bcr_followup_uuid	D5C36D39-DD0E-4691-A2EC-4DB0B847A268
clinical__clin_shared__day_of_form_completion	16
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	7
clinical__clin_shared__person_neoplasm_cancer_status	TUMOR FREE
clinical__clin_shared__platelet_result_count	179
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	YES
clinical__clin_shared__tissue_retrospective_collection_indicator	NO
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__viral_hepatitis_serology	Hepatitis B Surface Antigen
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2013
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	Mild
clinical__nte__new_tumor_event_after_initial_treatment	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G2
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T2
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	4c82a9ae-f0b8-4d4e-b6c7-95cc34e5c6b4
gdc__aliquots__concentration	0.17
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-G3-AAV7-01A-11R-A38M-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	acbc8d65-42d0-45f9-ad81-b29a2f88259c
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.88
gdc__analytes__analyte_id	bdf85af5-f4d7-48fb-bf51-1a69f6e607ae
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	5d259f26-3bef-4fe4-948b-495183f5f8be
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:32:47.609868-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	0ca82729-685f-516c-b65a-54f543d51dbd
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	asian
gdc__demographic__year_of_birth	1975
gdc__diagnoses__age_at_diagnosis	14229
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-14229.0
gdc__diagnoses__days_to_last_follow_up	361.0
gdc__diagnoses__diagnosis_id	e475b397-1382-57c4-b3ec-cd703141319f
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage ii
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	21.303948576675847
gdc__exposures__exposure_id	f62e3f71-cb38-5ff5-8c58-e874246af4ff
gdc__exposures__height	165.0
gdc__exposures__weight	58.0
gdc__file_id	38f2343c-274b-49b6-b2f6-a20448941210
gdc__file_name	61e93f10-1af1-47db-8a46-61aab938adad.mirbase21.mirnas.quantification.txt
gdc__file_size	50392
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	8211931233a774bc7ea29d6533a187f8
gdc__portions__is_ffpe	false
gdc__portions__portion_id	a63f8f43-7f4f-4afc-b4e5-5306d8d684c6
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	52
gdc__samples__initial_weight	120.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	0F368084-04F6-4DCE-9ADF-6B3B94D274AB
gdc__samples__sample_id	5cdd976b-bb2b-47a9-a745-ad446797ac34
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	0.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	10.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	2.0
gdc__slides__percent_tumor_cells	88.0
gdc__slides__percent_tumor_nuclei	95.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	bf13c1e8-e04a-4747-a10f-ca5d64ec3173
gdc__submitter_id	mirna_swap_dr11_158_MirnaExpressionf167c2ec-af62-4678-bc46-74fdd145ebcd_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	G3
gdc__tissue_source_site__name	Alberta Health Services
gdc__tissue_source_site__tissue_source_site_id	addd7b04-91a3-5179-99a5-cbff20df6bb4
gdc__treatments__treatment_id	ab033923-b297-5c02-8522-5d79b7708ddb
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:08:22.979+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/4c82a9ae-f0b8-4d4e-b6c7-95cc34e5c6b4-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/4c82a9ae-f0b8-4d4e-b6c7-95cc34e5c6b4-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129763
manually_curated__local_md5	86cdcc5ce25f36523875d39cce25b9d4
manually_curated__opengdc_download_date	2018-10-16T17:12:51.000152+02:00
manually_curated__opengdc_file_md5	64be0d206ee594712505dda642d0baf3
manually_curated__opengdc_file_size	50391
manually_curated__opengdc_id	4c82a9ae-f0b8-4d4e-b6c7-95cc34e5c6b4-meq
manually_curated__origin_file_size	129763
manually_curated__origin_last_modified_date	Tue Oct 16 17:54:00 CEST 2018
manually_curated__origin_md5	86cdcc5ce25f36523875d39cce25b9d4
manually_curated__tissue_status	tumoral
